Literature DB >> 28373397

Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and Excerpts.

Kevin J Donohoe1, Erica J Cohen1, Francesco Giammarile2, Erin Grady1, Bennett S Greenspan1, Robert E Henkin1, John Millstine1, Gary T Smith1, Sandy Srinivas3, Julie Kauffman1, Sukhjeet Ahuja1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28373397

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  11 in total

1.  A prospective intra-individual comparison of [68Ga]Ga-PSMA-11 PET/CT, [68Ga]Ga-NODAGAZOL PET/CT, and [99mTc]Tc-MDP bone scintigraphy for radionuclide imaging of prostate cancer skeletal metastases.

Authors:  Ismaheel O Lawal; Kgomotso M G Mokoala; Johncy Mahapane; Janke Kleyhans; Marian Meckel; Mariza Vorster; Thomas Ebenhan; Frank Rösch; Mike M Sathekge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-18       Impact factor: 9.236

Review 2.  Multimodality Imaging of Prostate Cancer.

Authors:  Soleen Ghafoor; Irene A Burger; Alberto H Vargas
Journal:  J Nucl Med       Date:  2019-09-03       Impact factor: 10.057

3.  A Bone Scan Is Valuable for Primary Staging of Newly Diagnosed Prostate Cancer in a Low-Resource Setting (Nigeria).

Authors:  Akintunde T Orunmuyi; Sikiru A Adebayo; Olayinka S Ilesanmi; Augustine O Takure; E Oluwabunmi Olapade-Olaopa
Journal:  Nucl Med Mol Imaging       Date:  2022-01-28

4.  Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research.

Authors:  Akintunde T Orunmuyi; Ismaheel O Lawal; Omonefe O Omofuma; Olalekan J Taiwo; Mike M Sathekge
Journal:  Ecancermedicalscience       Date:  2020-08-28

Review 5.  Molecular imaging of prostate cancer.

Authors:  Anne Marie Boustani; Darko Pucar; Lawrence Saperstein
Journal:  Br J Radiol       Date:  2018-02-01       Impact factor: 3.039

6.  Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement.

Authors:  Mikhail Kesler; Kosta Kerzhner; Ido Druckmann; Jonathan Kuten; Charles Levine; David Sarid; Daniel Keizman; Ofer Yossepowitch; Einat Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-27       Impact factor: 10.057

Review 7.  Review of imaging techniques for evaluating morphological and functional responses to the treatment of bone metastases in prostate and breast cancer.

Authors:  J Orcajo-Rincon; J Muñoz-Langa; J M Sepúlveda-Sánchez; G C Fernández-Pérez; M Martínez; E Noriega-Álvarez; S Sanz-Viedma; J C Vilanova; A Luna
Journal:  Clin Transl Oncol       Date:  2022-02-13       Impact factor: 3.340

8.  Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines.

Authors:  Kelsey L Pomykala; Johannes Czernin; Tristan R Grogan; Wesley R Armstrong; John Williams; Jeremie Calais
Journal:  J Nucl Med       Date:  2019-09-20       Impact factor: 11.082

9.  Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups.

Authors:  Sabina Sevcenco; Bernhard Grubmüller; Charlotte Sonneck-Koenne; Yasaman Ahmadi; Peter Knoll; Andreas Floth; Wolfgang Pokieser; Shahin Zandieh; Hans Christoph Klingler; Sharokh Shariat; Siroos Mirzaei
Journal:  Asia Ocean J Nucl Med Biol       Date:  2019

10.  Quantitative Analysis of SPECT-CT Data in Metastatic Breast Cancer Patients-The Clinical Significance.

Authors:  Mirela Gherghe; Mario-Demian Mutuleanu; Adina Elena Stanciu; Ionela Irimescu; Alexandra Lazar; Xenia Bacinschi; Rodica Maricela Anghel
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.